Plain-English translation of NCT06883305 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help people with moderate to very severe chronic obstructive pulmonary disease (COPD) have fewer flare-ups that require treatment. The medication is given as a monthly injection under the skin. Researchers want to know if this treatment is safe and whether it really works better than a placebo (a dummy injection with no active medicine).
Many people with severe COPD have frequent, serious flare-ups that can be life-threatening and require hospital visits or steroid treatments. This study exists to find out whether this new medication can help prevent those dangerous flare-ups and improve quality of life for people whose current treatments aren't controlling their symptoms well enough.
You likely qualify if…
You likely don't qualify if…
You would come to the clinic once a month for about 52 to 76 weeks to receive an injection under your skin. You would also have regular check-in visits to monitor how you're doing, answer questions about your symptoms, and have routine blood tests. After your last injection, you would have a 12-week follow-up period where the research team continues to check on your health. Some participants will receive the new medication and others will receive a placebo injection, but neither you nor your doctor will know which one you're getting until the study ends.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States